A. Sleijffers et al., Influence of ultraviolet B exposure on immune responses following hepatitis B vaccination in human volunteers, J INVES DER, 117(5), 2001, pp. 1144-1150
Exposure to ultraviolet radiation can modulate immune responses in animal a
nd humans. Remarkably, the ultraviolet-induced immunosuppression is not res
tricted to the exposed skin but is also found at other body sites, i.e., sy
stemic immunosuppression. Effects of ultraviolet radiation on infections ca
nnot be determined by experimentation on humans, but the effects of ultravi
olet on vaccination may serve as a model. Moreover, it is important in its
own right to assess whether ultraviolet radiation affects vaccination respo
nses. In this study the effect of ultraviolet B exposure on the development
of immune responses after hepatitis B vaccination in human volunteers was
investigated. To this end, 191 human volunteers were vaccinated against hep
atitis B with the Engerix-B (R) vaccine. Ninety-seven of them were prior to
the first vaccination exposed to ultraviolet B on 5 consecutive days with
one personal minimal erythema dose per day. At several time-points before a
nd after the ultraviolet B exposure regimen and the vaccination, blood samp
les were taken. Parameters for specific as well as nonspecific cellular and
humoral immunity were analyzed. It was demonstrated that ultraviolet B exp
osure prior to hepatitis B vaccination did not alter the cellular (lymphocy
te stimulation test) nor the humoral (antibody titers) immune response agai
nst hepatitis B surface antigen significantly. In contrast, contact hyperse
nsitivity to diphenylcyclopropenone was significantly suppressed after ultr
aviolet B exposure, as was natural killer cell activity. These latter resul
ts confirm earlier findings and demonstrate immunosuppressive effectiveness
of the ultraviolet regimen. In summary, although natural killer cell activ
ity and contact hypersensitivity responses were suppressed, the ultraviolet
B radiation protocol did not alter the humoral nor the cellular immune res
ponses against hepatitis B surface antigen after vaccination.